WINDTREE THERAPEUTICS INC /DE/ Quarterly Retained Earnings (Accumulated Deficit) in USD from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Windtree Therapeutics Inc /De/ quarterly Retained Earnings (Accumulated Deficit) history and growth rate from Q4 2010 to Q2 2024.
  • Windtree Therapeutics Inc /De/ Retained Earnings (Accumulated Deficit) for the quarter ending June 30, 2024 was -$847M, a 1.36% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 -$847M -$11.4M -1.36% Jun 30, 2024 10-Q 2024-08-19
Q1 2024 -$835M -$5.96M -0.72% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$845M -$20.3M -2.46% Dec 31, 2023 10-Q 2024-08-19
Q3 2023 -$840M -$24.8M -3.05% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$835M -$24.5M -3.02% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 -$829M -$35.2M -4.44% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 -$825M -$39.2M -4.99% Dec 31, 2022 10-K 2024-04-16
Q3 2022 -$815M -$42.6M -5.52% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 -$811M -$46.7M -6.12% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 -$793M -$66.8M -9.19% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 -$785M -$67.6M -9.42% Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$772M -$62M -8.73% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 -$764M -$62.8M -8.96% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 -$727M -$35M -5.06% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 -$718M -$32.6M -4.75% Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$710M -$32.5M -4.79% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 -$701M -$30.6M -4.56% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 -$692M -$27.5M -4.14% Mar 31, 2020 10-Q 2020-05-13
Q4 2019 -$685M -$27.5M -4.18% Dec 31, 2019 10-K 2021-03-29
Q3 2019 -$678M -$29.1M -4.49% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 -$671M -$25.9M -4.02% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 -$664M -$22.6M -3.52% Mar 31, 2019 10-Q 2019-05-20
Q4 2018 -$658M -$20.5M -3.22% Dec 31, 2018 10-K 2020-04-03
Q3 2018 -$649M -$9.02M -1.41% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 -$645M -$10.5M -1.66% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 -$642M -$14.2M -2.27% Mar 31, 2018 10-Q 2018-05-21
Q4 2017 -$637M -$18.4M -2.98% Dec 31, 2017 10-K/A 2019-04-23
Q3 2017 -$640M -$27.5M -4.5% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 -$634M -$30.4M -5.04% Jun 30, 2017 10-Q 2017-08-21
Q1 2017 -$627M -$34.3M -5.79% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 -$619M -$39.5M -6.82% Dec 31, 2016 10-K 2018-04-17
Q3 2016 -$612M -$43M -7.56% Sep 30, 2016 10-Q 2016-11-14
Q2 2016 -$604M -$56.2M -10.3% Jun 30, 2016 10-Q 2016-08-10
Q1 2016 -$593M -$56.9M -10.6% Mar 31, 2016 10-Q 2016-05-12
Q4 2015 -$579M -$55.2M -10.5% Dec 31, 2015 10-K 2017-03-31
Q3 2015 -$569M -$55.7M -10.8% Sep 30, 2015 10-Q 2015-11-05
Q2 2015 -$548M -$45.5M -9.06% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 -$536M -$44.8M -9.11% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 -$524M -$44.1M -9.18% Dec 31, 2014 10-K/A 2016-03-29
Q3 2014 -$513M -$45.2M -9.64% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 -$502M -$46.1M -10.1% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 -$491M -$44.1M -9.85% Mar 31, 2014 10-Q 2014-05-12
Q4 2013 -$480M -$45.2M -10.4% Dec 31, 2013 10-K 2015-03-16
Q3 2013 -$468M -$40.3M -9.42% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 -$456M -$41.4M -9.99% Jun 30, 2013 10-Q 2013-08-08
Q1 2013 -$447M -$39.9M -9.8% Mar 31, 2013 10-Q 2013-05-07
Q4 2012 -$435M -$37.3M -9.39% Dec 31, 2012 10-K 2014-03-17
Q3 2012 -$428M -$34.8M -8.85% Sep 30, 2012 10-Q 2012-11-14
Q2 2012 -$415M -$26.2M -6.75% Jun 30, 2012 10-Q 2012-08-14
Q1 2012 -$407M Mar 31, 2012 10-Q 2012-05-15
Q4 2011 -$397M -$21M -5.57% Dec 31, 2011 10-K 2013-03-15
Q3 2011 -$393M Sep 30, 2011 10-Q 2011-11-14
Q2 2011 -$388M Jun 30, 2011 10-Q 2011-08-15
Q4 2010 -$376M Dec 31, 2010 10-K 2012-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.